JP2005523698A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005523698A5 JP2005523698A5 JP2003587937A JP2003587937A JP2005523698A5 JP 2005523698 A5 JP2005523698 A5 JP 2005523698A5 JP 2003587937 A JP2003587937 A JP 2003587937A JP 2003587937 A JP2003587937 A JP 2003587937A JP 2005523698 A5 JP2005523698 A5 JP 2005523698A5
- Authority
- JP
- Japan
- Prior art keywords
- influenza
- virus
- amino acid
- group
- encoding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000712461 unidentified influenza virus Species 0.000 claims 59
- 210000004027 cell Anatomy 0.000 claims 32
- 238000000034 method Methods 0.000 claims 32
- 102000039446 nucleic acids Human genes 0.000 claims 29
- 108020004707 nucleic acids Proteins 0.000 claims 29
- 150000007523 nucleic acids Chemical class 0.000 claims 29
- 238000006467 substitution reaction Methods 0.000 claims 28
- 239000013598 vector Substances 0.000 claims 27
- 125000003275 alpha amino acid group Chemical group 0.000 claims 26
- 241000713196 Influenza B virus Species 0.000 claims 25
- 241000712431 Influenza A virus Species 0.000 claims 24
- 150000001413 amino acids Chemical class 0.000 claims 24
- 206010022000 influenza Diseases 0.000 claims 19
- 238000012258 culturing Methods 0.000 claims 14
- 241000700605 Viruses Species 0.000 claims 13
- 208000037798 influenza B Diseases 0.000 claims 13
- 239000000427 antigen Substances 0.000 claims 12
- 102000036639 antigens Human genes 0.000 claims 12
- 108091007433 antigens Proteins 0.000 claims 12
- 238000004113 cell culture Methods 0.000 claims 12
- 102220229450 rs779409525 Human genes 0.000 claims 11
- 102200153303 rs863224613 Human genes 0.000 claims 11
- 230000035772 mutation Effects 0.000 claims 10
- 241000713174 Influenza B virus (B/Ann Arbor/1/1966 [wild- type]) Species 0.000 claims 9
- 208000037797 influenza A Diseases 0.000 claims 8
- 239000013604 expression vector Substances 0.000 claims 7
- 238000004519 manufacturing process Methods 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 7
- 241000282341 Mustela putorius furo Species 0.000 claims 6
- 238000003556 assay Methods 0.000 claims 6
- 230000002238 attenuated effect Effects 0.000 claims 6
- 230000008488 polyadenylation Effects 0.000 claims 5
- 229960005486 vaccine Drugs 0.000 claims 5
- 210000003501 vero cell Anatomy 0.000 claims 5
- 230000029812 viral genome replication Effects 0.000 claims 5
- 241001500351 Influenzavirus A Species 0.000 claims 4
- 230000002457 bidirectional effect Effects 0.000 claims 4
- 230000002163 immunogen Effects 0.000 claims 4
- 229920001184 polypeptide Polymers 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 230000003362 replicative effect Effects 0.000 claims 4
- 230000006978 adaptation Effects 0.000 claims 3
- 230000035945 sensitivity Effects 0.000 claims 3
- 229940124873 Influenza virus vaccine Drugs 0.000 claims 2
- 230000004071 biological effect Effects 0.000 claims 2
- 238000010367 cloning Methods 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 230000000415 inactivating effect Effects 0.000 claims 2
- 229960001226 live attenuated influenza Drugs 0.000 claims 2
- 239000013612 plasmid Substances 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 230000010076 replication Effects 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 241001500350 Influenzavirus B Species 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000006143 cell culture medium Substances 0.000 claims 1
- 210000000991 chicken egg Anatomy 0.000 claims 1
- 235000013601 eggs Nutrition 0.000 claims 1
- 238000004520 electroporation Methods 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 229940033324 influenza A vaccine Drugs 0.000 claims 1
- -1 instructions Substances 0.000 claims 1
- 239000005022 packaging material Substances 0.000 claims 1
- 239000013600 plasmid vector Substances 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 239000012679 serum free medium Substances 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37567502P | 2002-04-26 | 2002-04-26 | |
| US39498302P | 2002-07-09 | 2002-07-09 | |
| US41057602P | 2002-09-12 | 2002-09-12 | |
| US41980202P | 2002-10-18 | 2002-10-18 | |
| US42070802P | 2002-10-23 | 2002-10-23 | |
| US45769903P | 2003-03-24 | 2003-03-24 | |
| US46236103P | 2003-04-10 | 2003-04-10 | |
| PCT/US2003/012728 WO2003091401A2 (en) | 2002-04-26 | 2003-04-25 | Multi plasmid system for the production of influenza virus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011103852A Division JP5303603B2 (ja) | 2002-04-26 | 2011-05-06 | インフルエンザウイルスの生産用多重プラスミドシステム |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005523698A JP2005523698A (ja) | 2005-08-11 |
| JP2005523698A5 true JP2005523698A5 (https=) | 2006-06-01 |
Family
ID=29273967
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003587937A Withdrawn JP2005523698A (ja) | 2002-04-26 | 2003-04-25 | インフルエンザウイルスの生産用多重プラスミドシステム |
| JP2011103852A Expired - Lifetime JP5303603B2 (ja) | 2002-04-26 | 2011-05-06 | インフルエンザウイルスの生産用多重プラスミドシステム |
| JP2013089445A Pending JP2013179943A (ja) | 2002-04-26 | 2013-04-22 | インフルエンザウイルスの生産用多重プラスミドシステム |
| JP2013131951A Pending JP2013230156A (ja) | 2002-04-26 | 2013-06-24 | インフルエンザウイルスの生産用多重プラスミドシステム |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011103852A Expired - Lifetime JP5303603B2 (ja) | 2002-04-26 | 2011-05-06 | インフルエンザウイルスの生産用多重プラスミドシステム |
| JP2013089445A Pending JP2013179943A (ja) | 2002-04-26 | 2013-04-22 | インフルエンザウイルスの生産用多重プラスミドシステム |
| JP2013131951A Pending JP2013230156A (ja) | 2002-04-26 | 2013-06-24 | インフルエンザウイルスの生産用多重プラスミドシステム |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US8012736B2 (https=) |
| EP (2) | EP2497826A1 (https=) |
| JP (4) | JP2005523698A (https=) |
| KR (2) | KR101169468B1 (https=) |
| CN (4) | CN103540613A (https=) |
| AR (2) | AR039465A1 (https=) |
| AU (2) | AU2003231083A1 (https=) |
| CA (1) | CA2482946C (https=) |
| DK (1) | DK1499348T3 (https=) |
| ES (1) | ES2526191T3 (https=) |
| TW (2) | TWI347363B (https=) |
| WO (1) | WO2003091401A2 (https=) |
Families Citing this family (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2319864T3 (es) | 2000-04-28 | 2009-05-14 | St. Jude Children's Research Hospital | Sistema de transfeccion de adn para la generacion de virus infecciosos de arn de cadena negativa. |
| ES2340499T3 (es) | 2001-06-05 | 2010-06-04 | Curevac Gmbh | Arnm de antigeno tumoral estabilizado con un contenido de g/c aumentado. |
| DK1499348T3 (en) | 2002-04-26 | 2015-01-05 | Medimmune Llc | PROCEDURE FOR PREPARING INFECTIOUS INFLUENZA B-VIRA IN CELL CULTURE |
| US7465456B2 (en) | 2002-04-26 | 2008-12-16 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
| EP2481819A1 (en) | 2003-02-25 | 2012-08-01 | MedImmune Vaccines, Inc. | Cross flow filtration in the production of stabilized influenza vaccine compositions |
| US20060110406A1 (en) | 2003-02-25 | 2006-05-25 | Medimmune Vaccines, Inc. | Refrigerator-temperature stable influenza vaccine compositions |
| WO2005028658A2 (en) * | 2003-05-28 | 2005-03-31 | Wisconsin Alumni Research Foundation | Recombinant influenza vectors with a polii promoter and ribozymes |
| US7566458B2 (en) | 2003-06-16 | 2009-07-28 | Medimmune, Llc | Influenza hemagglutinin and neuraminidase variants |
| CA2551489C (en) | 2003-12-23 | 2013-09-03 | Gregory Duke | Multi plasmid system for the production of influenza virus |
| HUE025727T2 (en) * | 2004-05-24 | 2016-04-28 | Medimmune Llc | Multi-plasmid system for producing influenza virus |
| JP4980895B2 (ja) * | 2004-05-25 | 2012-07-18 | メディミューン，エルエルシー | インフルエンザ赤血球凝集素およびノイラミニダーゼ変異体 |
| US20080044437A1 (en) * | 2004-09-02 | 2008-02-21 | Qun Chen | Encapsidation System for Production of Recombinant Virus-Like Particles |
| ATE489965T1 (de) * | 2004-09-09 | 2010-12-15 | Novartis Vaccines & Diagnostic | Verminderung von potentiellen iatrogenen risiken in verbindung mit influenza impfstoffen |
| EP1812564A2 (en) * | 2004-11-11 | 2007-08-01 | Solvay Pharmaceuticals B.V. | Defective influenza virus particles |
| CN101056976A (zh) * | 2004-11-11 | 2007-10-17 | 索尔瓦药物有限公司 | 有缺陷的流感病毒颗粒 |
| EA200701097A1 (ru) | 2004-11-19 | 2007-10-26 | Висконсин Эламни Рисёч Фаундэйшн | Рекомбинантные векторы вируса гриппа с тандемными транскрипционными единицами |
| US7510719B2 (en) * | 2004-12-08 | 2009-03-31 | Medimmune, Llc | Methods of producing influenza vaccine compositions |
| DK2368975T3 (en) | 2004-12-23 | 2015-01-05 | Medimmune Llc | Non-tumorigenic MDCK cell line for the propagation of viruses |
| EP2295542B1 (en) * | 2004-12-24 | 2013-01-30 | Abbott Biologicals B.V. | Rescue of influenza virus |
| EP2471552B1 (en) | 2005-03-08 | 2015-05-06 | MedImmune, LLC | Reassortant influenza viruses |
| US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| EP1917352A4 (en) | 2005-06-21 | 2009-03-25 | Medimmune Vaccines Inc | METHODS AND COMPOSITIONS FOR EXPRESSING HETEROLOGOUS PROTEASE |
| EP1945778B1 (en) | 2005-10-17 | 2012-12-26 | MedImmune, LLC | Methods of increasing influenza virus replication |
| CN101563361B (zh) * | 2005-10-19 | 2014-01-29 | 佛罗里达大学研究基金公司 | 能够感染犬科动物的流感病毒及其用途 |
| WO2007053696A2 (en) * | 2005-11-01 | 2007-05-10 | Alnylam Pharmaceuticals, Inc. | Rnai inhibition of influenza virus replication |
| ES2525518T3 (es) | 2005-11-01 | 2014-12-26 | Novartis Vaccines And Diagnostics Gmbh | Vacunas virales derivadas de células con niveles reducidos de ADN celular residual |
| CA2647985C (en) | 2006-03-31 | 2014-12-30 | Warf-Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines |
| DK2016194T3 (en) * | 2006-04-19 | 2015-06-15 | Medimmune Llc | METHODS AND COMPOSITIONS FOR EXPRESSION OF VIRAL NEGATIVE SENSE RNA IN DOG CELLS |
| US9072701B2 (en) | 2006-04-21 | 2015-07-07 | St. Jude Children's Research Hospital | Avian influenza viruses, vaccines, compositions, formulations, and methods |
| US7507411B2 (en) * | 2006-06-23 | 2009-03-24 | University Of Saskatchewan | Attenuated influenza NS1 variants |
| WO2008133701A1 (en) * | 2006-07-21 | 2008-11-06 | Medimmune, Llc. | Methods and compositions for increasing replication capacity of an influenza virus |
| CN104140958A (zh) * | 2006-08-09 | 2014-11-12 | 米迪缪尼有限公司 | 流感血凝素和神经氨酸酶变体 |
| EP2615167A1 (en) | 2006-09-15 | 2013-07-17 | MedImmune, LLC | Method for eliminating DNA contaminants from viral preparations |
| EP2674486A1 (en) * | 2007-06-18 | 2013-12-18 | MedImmune, LLC | Influenza B viruses having alterations in the hemaglutinin polypeptide |
| US9474798B2 (en) | 2007-06-18 | 2016-10-25 | Wisconsin Alumni Research Foundation | Influenza M2 protein mutant viruses as live influenza attenuated vaccines |
| EP2045323A1 (en) * | 2007-10-05 | 2009-04-08 | Avir Green Hills Biotechnology Research Development Trade Ag | Linear expression constructs for production of influenza virus particles |
| CA2705461A1 (en) * | 2007-11-12 | 2009-06-11 | The Trustees Of The University Of Pennsylvania | Vaccines against multiple subtypes of influenza virus |
| RU2523587C2 (ru) * | 2008-07-11 | 2014-07-20 | МЕДИММЬЮН, ЭлЭлСи | Варианты гемагглютинина и нейрамидазы вируса гриппа |
| US8785173B2 (en) | 2008-09-24 | 2014-07-22 | Medimmune, Llc | Methods for purification of viruses |
| WO2010046335A1 (en) * | 2008-10-21 | 2010-04-29 | Crucell Holland B.V. | Production of influenza virus by reverse genetics in per.c6 cells under serum free conditions |
| CN107365751B (zh) | 2008-12-16 | 2021-07-09 | 纳米医疗公司 | 流感疫苗的生产 |
| EP2233152A1 (en) | 2009-03-24 | 2010-09-29 | Avir Green Hills Biotechnology Research Development Trade Ag | High growth reassortant influenza A virus |
| SG173642A1 (en) | 2009-02-12 | 2011-09-29 | Medimmune Llc | Influenza hemagglutinin and neuraminidase variants |
| CA2778332A1 (en) * | 2009-10-20 | 2011-04-28 | Novartis Ag | Improved reverse genetics methods for virus rescue |
| EP2493912B1 (en) | 2009-10-26 | 2020-07-29 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses with enhanced replication in vero cells |
| KR101183199B1 (ko) | 2009-11-16 | 2012-09-14 | (주)지노믹트리 | 지노타이핑 방법 |
| US10130697B2 (en) | 2010-03-23 | 2018-11-20 | Wisconsin Alumni Research Foundation (Warf) | Vaccines comprising mutant attenuated influenza viruses |
| KR101323582B1 (ko) * | 2011-03-17 | 2013-10-30 | 충북대학교 산학협력단 | Ｖｅｒｏ 세포 유래의 ｐｏｌⅠ 프로모터 및 이를 포함하는 재조합 벡터 |
| US20130189303A1 (en) | 2011-08-02 | 2013-07-25 | Yan Zhou | Recombinant swine influenza virus and uses thereof |
| JP2014527799A (ja) | 2011-08-26 | 2014-10-23 | ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション | 変異型ｐｂ２遺伝子セグメントを有する弱毒化生ワクチンとしてのインフルエンザウイルス |
| CN102851258A (zh) * | 2011-09-08 | 2013-01-02 | 中国农业科学院上海兽医研究所 | 高效表达ha蛋白的重组流感病毒及其制备方法和应用 |
| CN102864127A (zh) * | 2011-09-08 | 2013-01-09 | 中国农业科学院上海兽医研究所 | 高效表达ha蛋白的重组流感病毒及其制备方法和应用 |
| CN102864130A (zh) * | 2011-09-08 | 2013-01-09 | 中国农业科学院上海兽医研究所 | 高效表达ha蛋白的重组流感病毒及其制备方法和应用 |
| US9017694B2 (en) | 2011-10-07 | 2015-04-28 | Medimmune, Llc | Swine influenza hemagglutinin variants |
| US11028408B2 (en) | 2012-05-25 | 2021-06-08 | University Of Maryland, College Park | Recombinant influenza viruses and constructs and uses thereof |
| KR101443983B1 (ko) * | 2012-12-04 | 2014-11-03 | 충북대학교 산학협력단 | Mdck 세포 특이적으로 증식성이 향상된 다중 돌연변이 인플루엔자 a 바이러스 |
| FR3004726A1 (fr) | 2013-04-18 | 2014-10-24 | Agronomique Inst Nat Rech | Mutants thermosensibles de virus influenza |
| WO2015009743A1 (en) | 2013-07-15 | 2015-01-22 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs |
| CN105518129B (zh) | 2013-07-19 | 2020-04-28 | 罗切斯特大学 | 减毒流感疫苗和其用途 |
| US10053671B2 (en) | 2014-06-20 | 2018-08-21 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to additional genes in influenza viruses |
| CN104450695B (zh) * | 2014-11-26 | 2017-08-25 | 扬州大学 | A型流感病毒基因pcr扩增引物及其快速克隆方法 |
| CN104592367B (zh) * | 2014-12-24 | 2019-01-18 | 中国科学院微生物研究所 | 流感病毒np蛋白突变体及其编码基因与应用 |
| WO2016172588A1 (en) | 2015-04-24 | 2016-10-27 | Andrew Cox | Attenuated influenza vaccines and uses thereof |
| US10633422B2 (en) | 2015-06-01 | 2020-04-28 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA |
| US9890363B2 (en) | 2015-07-06 | 2018-02-13 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication for vaccine development |
| US11197925B2 (en) | 2016-02-19 | 2021-12-14 | Wisconsin Alumni Research Foundation (Warf) | Influenza B virus replication for vaccine development |
| WO2018013704A1 (en) | 2016-07-12 | 2018-01-18 | Duke University | Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same |
| WO2019084310A1 (en) | 2017-10-25 | 2019-05-02 | Yoshihiro Kawaoka | HAS RECOMBINANT INFLUENZA VIRUSES STABILIZED FOR EGG REPLICATION |
| US12178869B2 (en) | 2017-12-22 | 2024-12-31 | Codagenix Inc. | Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer |
| WO2019172982A1 (en) | 2018-03-08 | 2019-09-12 | Codagenix Inc. | Attenuated flaviviruses |
| US12343390B2 (en) | 2018-08-07 | 2025-07-01 | Wisconsin Alumni Research Foundation (Warf) | Recombinant biologically contained filovirus vaccine |
| JP7655849B2 (ja) | 2018-08-20 | 2025-04-02 | ウィスコンシン アルムニ リサーチ ファンデイション | ヘマグルチニン（ｈａ）タンパク質内の非ドミナントエピトープに対する免疫応答を誘起するためのベクター |
| CN111363017B (zh) * | 2018-12-25 | 2022-03-15 | 中国科学院微生物研究所 | A型流感病毒核蛋白s69位突变序列及其突变体与应用 |
| EP3914295A2 (en) | 2019-01-23 | 2021-12-01 | Yoshihiro Kawaoka | Mutations that confer genetic stability to additional genes in influenza viruses |
| WO2020163768A1 (en) * | 2019-02-07 | 2020-08-13 | Duke University | Stabilized 9 and 10 segmented influenza viruses as a vaccine platform and methods of making and using same |
| EP3921413A1 (en) | 2019-02-08 | 2021-12-15 | Wisconsin Alumni Research Foundation (WARF) | Humanized cell line |
| US11214799B2 (en) * | 2019-03-12 | 2022-01-04 | The University Court Of The University Of Edinburg Old College | HA-specific influenza virus attenuated vaccine comprising mutations in segment 7, and uses therefor |
| CN114929269A (zh) | 2019-05-01 | 2022-08-19 | 威斯康星校友研究基金会(Warf) | 用于疫苗开发的改进的流感病毒复制 |
| CN110713988A (zh) * | 2019-05-13 | 2020-01-21 | 广州医科大学附属第一医院（广州呼吸中心） | 一种防止接种于鸡蛋的季节性人流感h3n2病毒抗原性降低的方法 |
| US11807872B2 (en) | 2019-08-27 | 2023-11-07 | Wisconsin Alumni Research Foundation (Warf) | Recombinant influenza viruses with stabilized HA for replication in eggs |
| JP2023511444A (ja) | 2020-01-24 | 2023-03-17 | ウィスコンシン アルムニ リサーチ ファンデイション | 安定化されたｎａを有する組換えインフルエンザウイルス |
| WO2021195410A1 (en) | 2020-03-25 | 2021-09-30 | Wisconsin Alumni Research Foundation (Warf) | Recombinant multivalent influenza viruses |
| EP4185601A4 (en) | 2020-07-21 | 2024-10-30 | Flugen, Inc. | SKELETON OF THE INFLUENZA VIRUS |
| CN117946982B (zh) * | 2022-12-30 | 2025-06-03 | 中国科学院微生物研究所 | H1n1流感病毒冷适应疫苗骨架毒株cv1-pr8及其构建方法和应用 |
Family Cites Families (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB660109A (en) | 1946-10-01 | 1951-10-31 | American Cyanamid Co | Improvements in or relating to the treatment of allantoic fluid containing a propagated virus together with non-viral proteins to obtain the virus in purified and viable from for use in a vaccine |
| US3992522A (en) * | 1973-01-24 | 1976-11-16 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Temperature-sensitive recombinant mutant viruses and a process for producing same |
| US3874999A (en) * | 1973-10-31 | 1975-04-01 | American Cyanamid Co | Process for the purification of virus vaccine |
| US4071618A (en) * | 1974-09-03 | 1978-01-31 | Research Foundation For Microbial Diseases Of Osaka University | Process for preparing virus disease live vaccines |
| US4000257A (en) * | 1975-12-22 | 1976-12-28 | American Cyanamid Company | Process for the purification of influenza virus vaccine |
| US4057626A (en) * | 1976-10-08 | 1977-11-08 | Richardson-Merrell Inc. | Process for detoxifying influenza B virus |
| US4338296A (en) * | 1979-10-16 | 1982-07-06 | Smithkline-Rit | Influenza virus and process of producing a vaccine therefrom |
| US4337242A (en) * | 1980-02-05 | 1982-06-29 | Merck & Co., Inc. | Vaccine stabilizer containing L-glutamic acid and L-arginine |
| US4512972A (en) * | 1980-06-30 | 1985-04-23 | Kureha Chemical Industry Co., Ltd. | Nasal preparation and processes for their production |
| JPS57136528A (en) * | 1981-02-09 | 1982-08-23 | Hayashibara Biochem Lab Inc | Preparation of viral vaccine |
| FR2505657A1 (fr) * | 1981-05-13 | 1982-11-19 | Pasteur Institut | Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation |
| US4512285A (en) * | 1983-12-27 | 1985-04-23 | Gof Manufacturing Company, Inc. | Apparatus and method for egg turning during incubation |
| US4634666A (en) * | 1984-01-06 | 1987-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | Human-murine hybridoma fusion partner |
| GB8914968D0 (en) | 1989-06-29 | 1989-08-23 | Connaught Lab | Production of virus and purification of viral envelope proteins for vaccine use |
| US5854037A (en) * | 1989-08-28 | 1998-12-29 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand RNA virus expression systems and vaccines |
| US5840520A (en) | 1989-08-28 | 1998-11-24 | Aviron | Recombinant negative strand RNA virus expression systems |
| US5166057A (en) | 1989-08-28 | 1992-11-24 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand rna virus expression-systems |
| US6887699B1 (en) * | 1990-05-22 | 2005-05-03 | Medimmune Vaccines, Inc. | Recombinant negative strand RNA virus expression systems and vaccines |
| EP1473361A3 (en) | 1992-04-14 | 2004-11-17 | The Mount Sinai School Of Medicine, Of The City University Of New York | Genetically engineered attenuated viruses |
| IL105456A (en) * | 1992-04-21 | 1996-12-05 | American Home Prod | Vaccines of attenuated respiratory syncytial virus |
| CA2075521C (en) * | 1992-05-05 | 1995-11-28 | Kuniaki Koyama | Stabilized live vaccine |
| ATE257175T1 (de) * | 1994-07-18 | 2004-01-15 | Conzelmann Karl Klaus Prof Dr | Rekombinantes infektiöses nicht-in-segmente- geteiltes, negativ-strange-rns-virus |
| US5824536A (en) * | 1994-08-23 | 1998-10-20 | St. Jude Children's Research Hospital | Influenza virus replicated in mammalian cell culture and vaccine production |
| US5716821A (en) * | 1994-09-30 | 1998-02-10 | Uab Research Foundation | Prevention and treatment of respiratory tract disease |
| AU3760495A (en) | 1994-09-30 | 1996-04-26 | Aviron | Chimeric Influenza Virus And Electroporation Method |
| US5789229A (en) * | 1994-09-30 | 1998-08-04 | Uab Research Foundation | Stranded RNA virus particles |
| US6146873A (en) * | 1994-11-10 | 2000-11-14 | Baxter Aktiengesellschaft | Production of orthomyxoviruses in monkey kidney cells using protein-free media |
| US7153510B1 (en) * | 1995-05-04 | 2006-12-26 | Yale University | Recombinant vesiculoviruses and their uses |
| US5690937A (en) * | 1995-06-05 | 1997-11-25 | Aviron | Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene |
| ATE181112T1 (de) | 1995-08-09 | 1999-06-15 | Schweiz Serum & Impfinst | Dem genom von minussträngigen rna-viren entsprechende cdna und verfahren zur herstellung von infektiösen minussträngigen rna-viren |
| US6264957B1 (en) | 1995-09-27 | 2001-07-24 | The United States Of America As Represented By The Department Of Health And Human Services | Product of infectious respiratory syncytial virus from cloned nucleotide sequences |
| ATE213646T1 (de) | 1995-10-20 | 2002-03-15 | Yissum Res Dev Co | Grippe-impfstoff |
| DK0864645T3 (da) | 1995-10-31 | 2005-10-24 | Dnavec Research Inc | Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet |
| DK0863202T3 (da) | 1995-11-01 | 2010-09-27 | Dnavec Research Inc | Rekombinant Sendai-virus |
| US6090391A (en) * | 1996-02-23 | 2000-07-18 | Aviron | Recombinant tryptophan mutants of influenza |
| DE19612966B4 (de) * | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren |
| EP1666587A1 (en) * | 1996-06-13 | 2006-06-07 | Astellas Pharma Inc. | Cyclic lipopeptide acylase |
| WO1998002530A1 (en) | 1996-07-15 | 1998-01-22 | The Government Of The United States Of America, As Represented By The Department Of Health And Human Services | Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| CA2265554A1 (en) | 1996-09-27 | 1998-04-02 | American Cyanamid Company | 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales |
| BR9809456B1 (pt) | 1997-05-23 | 2011-06-28 | molécula isolada de polinucleotìdeo, composição de célula ou isenta de célula, partìcula de piv infeciosa, atenuada e imunogênica, e, composição imunogênica. | |
| DE69837764T2 (de) | 1997-07-11 | 2008-01-31 | Yale University, New Haven | Rhabdovirus mit gentechnisch veränderter hülle |
| KR20010030630A (ko) | 1997-09-19 | 2001-04-16 | 윌리암 에이취 캘넌, 에곤 이 버그 | 약독화 호흡 신시티아 바이러스 |
| US6177082B1 (en) * | 1998-08-13 | 2001-01-23 | The University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
| US6544785B1 (en) * | 1998-09-14 | 2003-04-08 | Mount Sinai School Of Medicine Of New York University | Helper-free rescue of recombinant negative strand RNA viruses |
| US6146642A (en) * | 1998-09-14 | 2000-11-14 | Mount Sinai School Of Medicine, Of The City University Of New York | Recombinant new castle disease virus RNA expression systems and vaccines |
| AU1105800A (en) * | 1998-10-09 | 2000-05-01 | L. Sai Latha Shankar | Methods for treating multiple sclerosis |
| EP1035209A1 (en) | 1999-03-06 | 2000-09-13 | ARTEMIS Pharmaceuticals GmbH | Stable recombinant influenza viruses free of helper viruses |
| DE122008000035I1 (de) * | 1999-04-06 | 2009-05-20 | Wisconsin Alumni Res Found | Rekombinante influenzaviren zur vakzinherstellung und gentherapie |
| US8715940B2 (en) * | 1999-04-06 | 2014-05-06 | Wisconsin Alumni Research Foundation | Method of making recombinant influenza virus |
| GB9923176D0 (en) | 1999-09-30 | 1999-12-01 | Smithkline Beecham Biolog | Novel composition |
| WO2001064860A2 (en) * | 2000-03-02 | 2001-09-07 | Polymun Scientific Immunbiologische Forschung Gmbh | Recombinant influenza a viruses |
| ES2319864T3 (es) * | 2000-04-28 | 2009-05-14 | St. Jude Children's Research Hospital | Sistema de transfeccion de adn para la generacion de virus infecciosos de arn de cadena negativa. |
| JP5063852B2 (ja) * | 2000-09-25 | 2012-10-31 | ポリマン サイエンティフィック イミューンバイオロジッシュ フォーシュング ゲゼルシャフト ミット ベシュレンクテル ファフツング | 生ワクチン及び製造方法 |
| US7195905B2 (en) * | 2001-12-10 | 2007-03-27 | Baxter Healthcare S.A. | Enveloped virus vaccine and method for production |
| US7465456B2 (en) * | 2002-04-26 | 2008-12-16 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
| DK1499348T3 (en) | 2002-04-26 | 2015-01-05 | Medimmune Llc | PROCEDURE FOR PREPARING INFECTIOUS INFLUENZA B-VIRA IN CELL CULTURE |
| US20060110406A1 (en) * | 2003-02-25 | 2006-05-25 | Medimmune Vaccines, Inc. | Refrigerator-temperature stable influenza vaccine compositions |
| EP2481819A1 (en) | 2003-02-25 | 2012-08-01 | MedImmune Vaccines, Inc. | Cross flow filtration in the production of stabilized influenza vaccine compositions |
| US7566458B2 (en) * | 2003-06-16 | 2009-07-28 | Medimmune, Llc | Influenza hemagglutinin and neuraminidase variants |
| US7037707B2 (en) * | 2003-09-04 | 2006-05-02 | St. Jude Children's Research Hospital | Method for generating influenza viruses and vaccines |
| CA2551489C (en) | 2003-12-23 | 2013-09-03 | Gregory Duke | Multi plasmid system for the production of influenza virus |
| HUE025727T2 (en) | 2004-05-24 | 2016-04-28 | Medimmune Llc | Multi-plasmid system for producing influenza virus |
| EP2769735B1 (en) | 2004-10-06 | 2017-04-19 | MedImmune, LLC | Refrigerator-temperature stable influenza vaccine compositions |
| EP2388340B1 (en) | 2004-11-01 | 2013-04-03 | Eiken Kagaku Kabushiki Kaisha | Method of detecting H7 avian influenza virus |
| EP2674486A1 (en) * | 2007-06-18 | 2013-12-18 | MedImmune, LLC | Influenza B viruses having alterations in the hemaglutinin polypeptide |
| CN102026628A (zh) * | 2008-02-15 | 2011-04-20 | 太阳医药高级研发有限公司 | 具有降低崩裂效果的口服控释片剂 |
-
2003
- 2003-04-25 DK DK03724208.8T patent/DK1499348T3/en active
- 2003-04-25 KR KR20047017199A patent/KR101169468B1/ko not_active Expired - Lifetime
- 2003-04-25 CN CN201310365550.9A patent/CN103540613A/zh active Pending
- 2003-04-25 CN CN201310364981.3A patent/CN103540568A/zh active Pending
- 2003-04-25 US US10/423,828 patent/US8012736B2/en active Active
- 2003-04-25 CN CNA038151952A patent/CN1678345A/zh active Granted
- 2003-04-25 KR KR1020117011414A patent/KR101229202B1/ko not_active Expired - Lifetime
- 2003-04-25 EP EP20120168901 patent/EP2497826A1/en not_active Withdrawn
- 2003-04-25 EP EP03724208.8A patent/EP1499348B1/en not_active Expired - Lifetime
- 2003-04-25 WO PCT/US2003/012728 patent/WO2003091401A2/en not_active Ceased
- 2003-04-25 CA CA 2482946 patent/CA2482946C/en not_active Expired - Lifetime
- 2003-04-25 CN CN038151952A patent/CN1678345B/zh not_active Expired - Fee Related
- 2003-04-25 AU AU2003231083A patent/AU2003231083A1/en not_active Abandoned
- 2003-04-25 ES ES03724208.8T patent/ES2526191T3/es not_active Expired - Lifetime
- 2003-04-25 JP JP2003587937A patent/JP2005523698A/ja not_active Withdrawn
- 2003-04-28 TW TW099140358A patent/TWI347363B/zh not_active IP Right Cessation
- 2003-04-28 AR ARP030101459 patent/AR039465A1/es active IP Right Grant
- 2003-10-28 TW TW92109896A patent/TWI338047B/zh not_active IP Right Cessation
-
2009
- 2009-10-09 AU AU2009225296A patent/AU2009225296B2/en not_active Ceased
-
2011
- 2011-05-06 JP JP2011103852A patent/JP5303603B2/ja not_active Expired - Lifetime
- 2011-06-16 AR ARP110102084 patent/AR081941A2/es unknown
- 2011-08-19 US US13/214,110 patent/US8722059B2/en not_active Expired - Lifetime
-
2013
- 2013-04-22 JP JP2013089445A patent/JP2013179943A/ja active Pending
- 2013-06-24 JP JP2013131951A patent/JP2013230156A/ja active Pending
-
2014
- 2014-03-21 US US14/222,461 patent/US20140220075A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005523698A5 (https=) | ||
| US12186386B2 (en) | Recombinant RSV with silent mutations, vaccines, and methods related thereto | |
| ES2523587T3 (es) | Virus influenza B que tienen alteraciones en el polipéptido hemaglutinina | |
| US20230293660A1 (en) | Chimeric rsv, immunogenic compositions, and methods of use | |
| US7411058B2 (en) | Cold-adapted equine influenza viruses | |
| US20220125909A1 (en) | Chimeric rsv and hmpv f proteins, immunogenic compositions, and methods of use | |
| JP2024009058A (ja) | ラッサワクチン | |
| CN106754765B (zh) | 一种新城疫病毒样颗粒、制备方法及其应用 | |
| CN111154778B (zh) | 禽新城疫病毒新型基因工程亚单位疫苗 | |
| US9370563B2 (en) | Newcastle disease virus and the use thereof as a vaccine | |
| CN114316071A (zh) | 一种重组腮腺炎病毒颗粒、组合物及其用途 | |
| CN113005100B (zh) | 一种改变囊膜病毒热稳定性的遗传改造方法及重组病毒与其应用 | |
| WO1997041245A1 (en) | Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins | |
| PT1194580E (pt) | Recostituição in victro de vírus de rna de cadeia negativa segmentados | |
| WO1995008634A1 (en) | Method for generating influenza a viruses bearing attenuating mutations in internal protein genes | |
| JPH08511424A (ja) | 高収量性インフルエンザウイルス | |
| CN112111467A (zh) | 一种基因vii型新城疫标记疫苗株及其制备方法与应用 | |
| US20240082385A1 (en) | Rsv vaccines and methods of administering same | |
| CA2906606C (en) | Recombinant rsv with silent mutations, vaccines, and methods related thereto | |
| RU2132877C1 (ru) | Фрагмент рекомбинантной рнк (варианты), рибонуклеопротеиновый комплекс (варианты), плазмида | |
| US6875436B1 (en) | Method for producing cell-fushion type morbillivirus mutants | |
| JP2006121948A (ja) | 組換えウイルス | |
| OA19870A (en) | Lassa vaccine. |